Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
about
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyNormal and neoplastic urothelial stem cells: getting to the root of the problemClinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer.Prognostic factors in renal cell and bladder cancer.The genetics of transitional cell carcinoma: progress and potential clinical application.Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma.What we could do now: molecular pathology of bladder cancer.Molecular mechanisms and pathways in bladder cancer development and progression.pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus.Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cellsBiomarkers for bladder cancer management: present and future.Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy.Epidermal growth factor receptor and bladder cancer.Pathobiology and chemoprevention of bladder cancerStatus of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters.Low ANXA10 expression is associated with disease aggressiveness in bladder cancerDetection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implicationsUrinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.Retinoblastoma gene mutations in primary human bladder cancerExpression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomasExpression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG).Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Developing innovative strategies for advanced transitional cell carcinoma of the bladder.Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome.Nonplatinum therapy in advanced bladder cancer.An immunohistochemical study of retinoblastoma gene product in normal, premalignant and malignant tissues of the uterine cervixG1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer.Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer.Molecular markers for bladder cancer: the road to a multimarker approach.Predicting survival after radical cystectomy for bladder cancer.
P2860
Q24604540-F717621B-7A06-40FA-89D6-959017FB9DBCQ26825948-05142C1B-B4C3-470A-9F68-D6A7061C20FEQ33403088-2E21058A-13C0-47A8-A20F-7BA1B796D89BQ33658216-32E08947-0FF8-4A88-90AC-E4F5B0878B1CQ33723575-A8F550AD-15A8-4241-B115-A3F2922EB173Q33867671-EF43F0F2-C26A-437B-959E-909BDDDBFF8DQ33918737-7D71012C-8B0B-44F7-97CC-0CDC264E2536Q33968710-6B8B5E73-A64F-41D9-8F1E-0B3769B2E741Q34099399-FA53EB76-C132-479D-9A39-E06B5E1F31D2Q34174124-856EB5D2-2848-4A84-AA14-1EC02696254BQ34448168-07859155-5F49-4EB4-942A-7C2A111F05A8Q34585359-976632DB-5B8C-4A20-A83F-DD4AFD89AC91Q34866510-CD7E15B1-4EDE-47EC-8510-6FF23331CE04Q34988074-F4F50353-89A3-4BEE-B2F4-B2AED30D38CDQ35219328-3A47EC89-763E-4676-990A-36AD03228428Q35588461-DE88D1D1-3EF2-4DC0-823D-9E86A6B4E5C4Q35620687-064447AF-8909-4603-B5EB-11983A524EA0Q35764156-FDAFBCA2-9F78-426B-A188-9D37508FAE3DQ35764748-0E62B362-CAE8-4814-9816-76623AFFCBE4Q35786303-2F7646E1-B46F-48C2-B507-D729AFC3B934Q35788260-DE3B0C6F-017E-4763-ACA8-2CDB17194B32Q35798342-176913F1-7316-4F9B-9E7F-1EA210D375ADQ36080738-4F368F81-07C0-4C09-8752-FA0C91F25A2FQ36080777-C0345797-0DB1-453E-A58B-F031715D2D08Q36081239-7259AEC3-D908-4632-B7B4-171BC16A5DB8Q36081670-B70B10CC-892E-4033-B9F2-15FB09744B4CQ36141183-947911E5-6845-480B-B799-A536096C0EB2Q36334889-DA73E1B3-E166-4954-B535-7ACF58457FEDQ36341182-18D80760-E609-436B-8676-69DC2A830238Q36352085-36B4E960-9890-4ED2-8819-439F3B5C91A8Q36352713-1B798D7F-9A52-441A-A99D-C2403CC0CC0EQ36500541-5984CA5E-496E-49C1-85A6-75347A385147Q36568051-0EDC55F4-1995-4AAD-B26C-0F4D97B96B59Q36618000-421E5AE3-B197-4845-B041-0BCEB538C7E7Q36622949-00E4F19D-5710-4CCF-9807-7C061D00F04CQ36670961-5A9296C0-6A6C-466F-8FEE-B72AFEBAB851Q36820882-7F6C19E8-6982-46AF-8EAE-EB928CABF75AQ36992619-CCF340F5-5332-4CEC-9E79-2EF2017C0548Q37025942-015B8D43-ED43-4F5A-BF03-8297E990F29FQ37103989-B08ABC6E-DE43-4637-9D8A-4D7EA908141D
P2860
Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Altered expression of the reti ...... c indicator in bladder cancer.
@en
type
label
Altered expression of the reti ...... c indicator in bladder cancer.
@en
prefLabel
Altered expression of the reti ...... c indicator in bladder cancer.
@en
P2093
P356
P1476
Altered expression of the reti ...... c indicator in bladder cancer.
@en
P2093
Cordon-Cardo C
Dalbagni G
Petrylak D
Wartinger D
P304
P356
10.1093/JNCI/84.16.1251
P407
P577
1992-08-01T00:00:00Z